Proposed tariffs on generic drugs in the US market, announced on August 1st, affect Biocon, whose executive chairperson is Kiran Mazumdar-Shaw.
1 report, 1 independent
Updated Aug 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Proposed tariffs on generic drugs in the US market, announced on August 1st, affect Biocon, whose executive chairperson is Kiran Mazumdar-Shaw.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
-
Biocon
an Indian biopharmaceutical company
Nothing else this week.
Related events
- Donald Trump announced potential tariffs on goods imported from India.
- Global tariffs from Donald Trump began on August 4, 2025, impacting international markets and financial news services like Bloomberg L.P.
- Donald Trump imposed tariffs on Boeing on July 5, 2026.
- Roberta Metsola advised Germany to seek a deal with the Trump administration amid an ongoing drug pricing trade dispute.